Lena Wiedmann is currently a Scientist in Immunomodulators at BioNTech, working on preclinical immuno-oncology projects focused on bispecific antibody combination therapies. Previously, Lena held the position of Manager of Histology Lab Operations at BioNTech, overseeing clinical trial processes for individualized mRNA therapies for cancer patients. Lena completed a PhD in Oncology and Cancer Biology at DKFZ German Cancer Research Center, and has also served as a postdoctoral researcher studying tumor microenvironments and fibrosis. Lena's academic background includes a Master of Science and Bachelor of Science in Technical Biology from Universität Stuttgart.
This person is not in the org chart
This person is not in any teams
This person is not in any offices